Close X

Welcome to the Contingent Commitment Exchange

Terminal Logo


Terminal is the live negotiation environment. Terminal access is restricted to approved users, to request access or you are having trouble logging in, contact


Sandbox is designed as a simulation environment which supports the full PharmaCCX platform functionality for training and practicing negotiations with no real world consequences. Reach out to to get a demo and sign up for access.

Close X

Supporting the Future of Market Access

CCX has deployed tools that can be used today, but have a vision for broader changes to market access. We work with our clients and experts from payers and pharma to help us navigate to that future.

Theory of Change

Getting new medicines to market is becoming more complex. Market access leaders across pharma, payer and HTA organizations are beginning to deploy digital tools to empower their teams to accomplish more with limited resources. The benefits in efficiency and business outcomes are compelling.
We believe that the key is to start with initiatives that create quick wins and build organizational momentum toward deeper transformation as the benefits compound. This usually means initially handing some mundane aspects of market access coordination over to technology so you and your team can focus on the truly important work that there never seems to be enough time to do. Likewise, it’s often best to start with things you can implement unilaterally before moving on to things that require coordination among multiple departments or organizations.
Read more in our practical guide to digitizing market access.
Images created with the assistance of DALL-E

Advisory Board

Meet some of the leaders from Payers, HTA, and Pharma that we work with:
Carole Longson
HTA and Market Access Expert
Former Executive Director at NICE
Brian O'Rourke
President of ISPOR
Former CEO of CADTH
Walter Hölzle
Hölzle, Buri & Partner Consulting
Former GM Warner-Lambert, Switzerland
Mel Walker
Managing Director Biopharma Futures
Formerly at GSK, Otsuka, Roche
Sean Tunis
Principal Rubix Health
Former CMO at CMS
Mark Trusheim
Strategic Director at NEWDIGS
Blake Dark
Senior Partner at Newmarket Strategy
Former Commercial Medicines Director at NHS
Steve Pearson
Founder and Special Advisor at ICER (Institute for Clinical and Economic Review)

Leadership Team

Nathan Sigworth
Co-Founder & CEO

A health-tech entrepreneur who formerly co-founded and was CEO of PharmaSecure, which uses serialization to prevent counterfeit drugs from entering the global pharmaceutical supply chain. Nathan is a graduate of Dartmouth College.

Peter Rice
Chief Operating Officer

An operations expert who was formerly Chief of Staff at Formlabs, and who spent a decade developing strategy, program and product management for (ALRM). Peter is a graduate of Colby College (BA) and Thayer School of Engineering at Dartmouth College (BE, MEM).

Alexander Klippel
Head of Engineering

A seasoned software engineer, Alex worked at Student Universe and SipLink on their software teams before he joined the CCX team in 2019. Alex was trained as a Civil Engineer at Aachen University in Germany and practiced as an engineer in Germany and Spain prior to switching to Software.

Cole Boskey
Commercial Lead

A well-rounded executive having had roles at Goldman Sachs, Autodesk, and with the Commonwealth of Massachusetts. He also has experience as a founder of his own healthcare startup, Wellable. Cole is a graduate of the Harvard Kennedy School (MPP), The Tuck School of Business at Dartmouth (MBA), and Boston College (BA).

Barath Shankar Subramanian

Partner at Accel

Julia Bernstein

COO at Brightside Health

Rob Kniaz

Partner at Hoxton Ventures & H Tree Capital